Impact of time to relapse and response to salvage therapy on post autologous stem cell transplant outcomes in relapsed or refractory diffuse large B-cell lymphoma.

被引：0
|
作者：
Tun, Aung M.
Wang, Yucai
Maliske, Seth
Farooq, Umar
Micallef, Ivana N. M.
Inwards, David James
Porrata, Luis F.
Ansell, Stephen M.
Rosenthal, Allison Claire
Kharfan-Dabaja, Mohamed
Link, Brian K.
Villasboas, Jose Caetano
Paludo, Jonas
Cerhan, James Robert
Habermann, Thomas Matthew
Witzig, Thomas E.
Nowakowski, Grzegorz S.
Johnston, Patrick B.
机构：
[1] Univ Kansas, Canc Ctr, Westwood, KS USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Univ Iowa, Iowa City, IA USA
[4] Univ Iowa, Carver Coll Med, Iowa City, IA USA
[5] Mayo Clin, Div Hematol, Rochester, MN USA
[6] Mayo Clin, Div Hematol, Phoenix, AZ USA
[7] Mayo Clin, Div Hematol Oncol, Jacksonville, FL 32224 USA
[8] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e19501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19501
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Factors influencing the outcome of autologous stem cell transplant at first sensitive relapse in 247 adults with diffuse large B-cell lymphoma.
    Guglielmi, C
    Gomez, F
    Garcia, EC
    BLOOD, 2000, 96 (11) : 794A - 794A
  • [22] Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review
    Tian, Linyan
    Li, Cheng
    Sun, Juan
    Zhai, Yixin
    Wang, Jinhuan
    Liu, Su
    Jiang, Yanan
    Wu, Wenqi
    Xing, Donghui
    Lv, Yangyang
    Guo, Jing
    Xu, Hong
    Sun, Huimeng
    Li, Yuhang
    Li, Lanfang
    Zhao, Zhigang
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [23] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Kato, Koji
    Sugio, Takeshi
    Ikeda, Takashi
    Yoshitsugu, Kanako
    Miyazaki, Kana
    Suzumiya, Junji
    Yamamoto, Go
    Kim, Sung-Won
    Ikegame, Kazuhiro
    Uehara, Yasufumi
    Mori, Yasuo
    Ishikawa, Jun
    Hiramoto, Nobuhiro
    Eto, Tetsuya
    Nakazawa, Hideyuki
    Kobayashi, Hikaru
    Serizawa, Kentaro
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzuki, Ritsuro
    BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 306 - 314
  • [24] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Koji Kato
    Takeshi Sugio
    Takashi Ikeda
    Kanako Yoshitsugu
    Kana Miyazaki
    Junji Suzumiya
    Go Yamamoto
    Sung-Won Kim
    Kazuhiro Ikegame
    Yasufumi Uehara
    Yasuo Mori
    Jun Ishikawa
    Nobuhiro Hiramoto
    Tetsuya Eto
    Hideyuki Nakazawa
    Hikaru Kobayashi
    Kentaro Serizawa
    Makoto Onizuka
    Takahiro Fukuda
    Yoshiko Atsuta
    Ritsuro Suzuki
    Bone Marrow Transplantation, 2024, 59 : 306 - 314
  • [25] Response to Salvage Therapy, The Main Prognosis Factor in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma Treated with R-ESHAP and Autologous Stem Cell Transplantation
    Salido Toimil, F.
    Torres Carrete, P.
    Deben Ariznavarreta, G.
    Varela Gomez, M. R.
    Lopez Fernandez, M. F.
    Noriega Concepcion, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S300 - S301
  • [26] Consolidative Radiotherapy After Autologous Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B-cell Lymphoma
    Coutu, Brendan G.
    Wilke, Christopher T.
    Yuan, Jianling
    Cao, Qing
    Vernon, Matthew R.
    Lee, Chung
    Bachanova, Veronika
    Dusenbery, Kathryn E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : 65 - 73
  • [27] AUTOLOGOUS STEM CELL TRANSPLANT FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: A SINGLE INSTITUTION EXPERIENCE
    Terol, M.
    Perez, A.
    Garcvia-Sanchis, L.
    Teruel, A.
    Goterris, R.
    Hernandez-Boluda, J.
    Arbona, C.
    Solano, C.
    HAEMATOLOGICA, 2012, 97 : 653 - 654
  • [28] Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era
    Nagle, Sarah J.
    Woo, Kaitlin
    Schuster, Stephen J.
    Nasta, Sunita D.
    Stadtmauer, Edward
    Mick, Rosemarie
    Svoboda, Jakub
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (10) : 890 - 894
  • [29] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma (PMLCL) are inferior to diffuse large B cell lymphoma (DLBCL).
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Keating, A
    Crump, M
    BLOOD, 2005, 106 (11) : 590A - 590A
  • [30] Predictors of Relapse and Survival Following Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma
    Hu, Marie
    Watkins, Marcus P.
    Cao, Qing
    Raya, Saba
    Germain, David A. Russler
    Bachanova, Veronika
    Fehniger, Todd A.
    Weisdorf, Daniel J.
    BLOOD, 2021, 138 : 1832 - +
12345